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Abstract
Introduction: This study sought to examine the contribution of relationship building (in terms of collaboration, information
sharing and supply chain interdependence) on the availability of malaria treatment pills in public hospitals in Sub-Saharan
Africa using data from Uganda.
Methods: By means of a cross-sectional survey research design, the study used a questionnaire strategy to collect quan-
titative data. Out of the 320 questionnaires that were distributed in 40 public hospitals, 283 were answered and returned,
which yielded an 88% response rate. Structural equation modelling (SEM) was used to establish the relationship between
measured variables and latent constructs.
Results: Drawing on the survey results, the confirmatory factor analysist and the Structural Equation Modelling clearly
demonstrate that relationship building (in terms of collaboration, information sharing and supply chain interdependence)
significantly influences the availability of Artemisinin-based combination therapies in public general hospitals in Uganda.
Conclusion: Policy-makers should focus on developing cheaper information technology tools to exchange information
regarding stock levels, forecasting, quantification, orders, and dispensing. This study developed a measurement model for an
inter-hospital relationship, using relational view theory, and it employs dimensions in terms of information sharing and supply
chain interdependence to predict and explain the availability of malaria pills in government hospitals.
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Introduction
Medicines are strategic products, and their availability is
a necessity, despite the complexity involved in managing
the various stakeholders such as regulatory authorities,
ministries, medicine manufacturers, distributors, whole-
salers, retailers, customers, and information service pro-
viders.1 Regrettably, there is a scarcity of research in the
area of medicine supply chains.2 Therefore, coordinating
the medicine supply chain is vital whether in developed,
emerging, or underdeveloped economies, despite the lack
of research on the topic.3 The availability of medicine is
considered to be one of the activities with the most sig-
nificant potential impact on human life; therefore, the
need to coordinate it.4
Medicine supply chain coordination is defined as
managing the interdependencies among the various
actors internally and externally to the hospital to make
health care delivery efficient and effective.5 In particular,
the planning or forecasting, quantification, procure-
ment, storage, and dispensing should be synchronized
to reduce stock-outs or variabilities.6 Attempts to
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ensure the availability of medicines can strengthen the
overall health system’s responsiveness to the treatment
of the patients.7 Unfortunately, the stock-out of
Artemisinin-based combination therapies (ACTS),
which that have been approved by the World Health
Organization (WHO) to treat uncomplicated malaria
in health facilities in developing countries, has put
many lives at risk and has sometimes led to death.8
In Kenya, several case studies.9,10 have established
that a mix of strategies was required to stabilize the
artemisinin (ACTs) market to avert death among chil-
dren under five and pregnant women. Similarly, another
study11 concluded that “the public health and private
retail sector are important complementary sources of
treatment in rural Tanzania for ACTs successful
uptake”. The same recommendation was made in
Ghana to control deaths as a result of complicated
malaria.12 A case study13 on Uganda advised that the
private sector should be included in healthcare provision
and should be encouraged to subsidize ACTs. This may
lead to a dramatic improvement in the availability and
improved uptake, and reduced deaths. Also in Uganda,
a study14 examined case studies of four rural districts in
Uganda, and concluded that the failure of coordination
was increasing the death burden on already pressured
hospitals.
From the foregoing, it is clear that the frequent
unabated unavailability of malarial drugs is of urgent
global concern, as over 3.7 billion people are at risk of
contracting malaria. In Africa alone, malaria is respon-
sible for almost four deaths every five minutes. In 2019,
229 million cases led to 409,000 deaths; of these 67%
(274,000) were children under 5 years.15 In Uganda,
malaria is the leading human killer, especially among
children under five years and expectant mothers.16
Several studies that have advanced a number of predic-
tors of the availability of malaria treatment pills have
found key enablers to include the use of cheaper infor-
mation technologies.12,17,18 Research19 has emphasized
that record keeping, employee training, supervisory
and regulatory support needs to be strengthened.
Similarly, a study20 surveyed the internal chain orienta-
tions, particularly patient care units, hospital warehouse,
patients, and the external chain consisting of distribu-
tors, vendors, and manufacturers. Previous studies
have theoretically embraced transaction cost economic
perspectives, while others have adopted the resource-
based view and coordination theory to predict the avail-
ability of services and products in organisations.21
This study developed a measurement model for an
inter-hospital relationship using the relational view
theory. It employs the dimensions in collaboration,
information sharing, and supply chain interdependence
to predict and explain malaria pills’ availability in Sub-
Saharan Africa.22 This re-conceptualized model is
validated by a large-scale empirical study involving
283 Drug Therapeutic Management Committee
(DTMC) members from 40 general public hospitals.
Confirmatory factor analysis was used to assess the con-
struct validity of the new measurement model.
With the increasing need for the availability of med-
ical products and services, the public and companies are
always looking for reliable suppliers. Hence, the need to
build a buyer-supplier relationship to achieve long-term
mutual benefits in terms of quality, efficiency, perfor-
mance, opportunities, and competence.23 However,
there is a lack of relationship building in the public
sector in Uganda, and where it exists, opportunism
and corruption are the order of the day.24 An earlier
survey25 found that relationship building is hampered
by unethical conduct among procurement professionals
in Uganda. Similarly, it was found that incentive align-
ment and information sharing were critical conjecturers
of decision synchronization.23 These factors may cause
citizenry dissatisfaction; late deliveries, and stock-outs of
products in the supply chain. The following section
describes the hypothesis and model development.
Hypotheses Development
This study first adopted the conceptualization of collab-
orative relationships from Simatupang and Sridharan.26
The study further adopted the conceptual framework
developed by Nagitta and Mkansi5 from a qualitative
study. However, this paper aimed at measuring and val-
idating the model.This study, therefore, aimed to test and
validate the initial qualitative findings from the above
scholars using a survey. The conceptualization of the col-
laborative partnership was conceived to involve joint
training with external partners such as the Uganda
National Medical Stores (NMS), Drug Monitoring
Unit, Ministry of Health, and Non-Governmental
Organizations. Information sharing involved variables
such as the timely sharing of information with other
stakeholders, credibility of shared information, sharing
of delivery schedules, and exchange of evaluation reviews
with external stakeholders. Finally, the constructs of
supply chain interdependence involved variables such as
the pooling of resources, standardization of processes,
joint planning and mutual adjustment. In developing
the hypotheses, this section reviews the literature on col-
laborative partnerships, information sharing, and the
management of supply chain interdependence, and there-
after, they are tested.
Collaborative Partnerships and Availability of ACTs
The term ‘collaborative partnership’ refers to organiza-
tions working with each other towards a common goal
instead of individually.27 The management of medicine
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supply chains necessitates partners’ capability to dis-
close, account, and scrutinize information flow.
Therefore, in performing such actions, the collaboration
with committed suppliers and other stakeholders of
products and services should reduce stock-outs or deliv-
er the needed medical supplies. Without focused collab-
oration and information sharing, it may be difficult for
individual hospitals to make medical supplies avail-
able.12,28 However, chain partners often opportunistical-
ly misuse their powers rather than creating better overall
value, therefore, this calls for proposals to explain the
interplay of power and trust mechanisms in collabora-
tive interactions.29 Nevertheless, supply chain entities
and actors must integrate and act on similar terms to
improve the flow of services and products, including
financial information and overall economic impacts.30
Collaboration is characterized by a higher-level inter-
est, representing an affective, volitional, shared interest
process.31 Other scholars32 stress the importance of the
shared interest by including the term “unity of effort.”
There must be some form of investment in the relation-
ship that provides for mutual understanding, a shared
vision, shared resources, and the achievement of collec-
tive goals.33 Collaboration between firms is a powerful
competitive advantage source, calling for the effective
management of relationships in the supply chain. This
includes the development and maintenance of capabili-
ties to ensure the effective delivery of medical products
and services.34 proposed strategic alliances between the
organization and suppliers, manufacturers, and distrib-
utors to produce and market ACTs. These scholars dem-
onstrated the relevance of the development of
coordination frameworks to enhance the strategic man-
agement of ACTs, and argued that the interaction of the
micro-market and macro environments is vital for the
supply and distribution of ACTs. They recommended
that joint internal coordination frameworks are neces-
sary for the successful availability of malarial drugs.
Relatedly, collaboration is emphasized while seeking
malaria treatment based on the need for malarial drugs
in both the public and private sectors. Therefore, the
following hypothesis is set forth:
H1: There is a relationship between collaborations and
availability of ACTs
Information Sharing and Availability of ACTs
Information sharing synchronizes the supply chain
members’ knowledge and expertise to increase the ability
to serve downstream customers efficiently. The coordi-
nated information includes, among others, changes in
market demand and customer preferences, and helps to
coordinate transaction-related activities.35 Coordinated
information is characterized by multiple dimensions,
including timeliness, accuracy, adequacy, completeness,
and information credibility.36 The supply chain interven-
tion’s primary goals are to improve stocking levels of
essential medicines, to and reduce the incidence and
duration of pharmaceutical stock-outs.37 Therefore, an
effective supply chain plays a critical role in improving
the health system performance regarding the general
behavioral aspects of the health system.7
However, sometimes firms are reluctant to share
information because of a lack of trust, leading to unco-
ordinated activities within the functional units.38 The
information helps to link the point of production seam-
lessly with the point of delivery or purchase. It allows
planning, tracking, and estimating the lead times based
on real-time data. Sharing of the information between
the supply chain members is very important for effective
coordination in the supply chain.39 According to Kabra
et al.,40 the sharing of information between supply chain
members helps to substitute information with inventory
and lead time, reduces the supply chain costs, reduces
the demand variability, enhances responsiveness, and
improves the service level. Available empiricism, as
investigated by Prajogo et al.41 found out that informa-
tion technology capabilities, particularly, have signifi-
cant positive effects on integrated supply and
distribution systems. The same study demonstrates that
long-term supplier relationships have direct effects on
logistics integration. However, sharing supply informa-
tion among the general hospitals and donors remain a
challenge in Sub-Saharan Africa.42 The effective
exchange of information with external suppliers is cru-
cial for the supply chain delivery of health products.41
Following the reviewed literature, it is hypothesized that:
H2: There is a relationship between information sharing
and the availability of ACTs
Management of Supply-Chain Interdependence and
Availability of ACTs
The past decade has been characterized by pulling data
together using different strategies towards an integrated
supply chain from both suppliers and customers.43,44
notes that managing supply-chain interdependence is a
critical factor for organisations in various industries. It
has potential benefits for firms’ performance, resulting
from the interdependencies of supplier business relation-
ships.45 Research on Kenya’s Public Health Sector46
found that the effective management of the health
sector requires the efficient integration of the hospital
processes using information technology tools so that
products are provided adequately at the right time and
delivered at the right places. This minimizes system-wide
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cost implications, while satisfying service requirements.
Studies have shown that partners can easily adjust or
vary fixed contractual terms, such as cost or budget
pressures and volume adjustments, among others,
when supply chain processes are integrated.47 By this
very fact, a high level of total interdependence, like the
one in Uganda between NMS and health facilities, might
indicate a strong, cooperative, long-term relationship.
Both parties have invested time, effort, and money.48
These scholars demonstrate that supply-chain interde-
pendence ensures that medicines do not expire in any
health facility, while there are either public or private
outlets that do not have stocks. Therefore, we hypothe-
sized that:
H3: There is a relationship between supply-chain inter-
dependence and the availability of ACTs
Methods
Research Philosophy and Approach
This study aimed to establish the cardinal parameters
that influence the availability of ACT supply in
Uganda to enhance malaria drug availability. The
study employed the pragmatism approach to verify the
relationship between the tested variables, because of its
practical and real strategy of resolving challenges.
Pragmatism allowed quantitative approaches to scale
the strength of variables/parameters that might impact
the availability of ACTs in the medical sector. The fun-
damental question in relation to this problem is how
supply chain variables can enhance ACTs’ availability
in developing economies, a case for Uganda.
Data Collection Method and Pilot Study
The study adopted a cross-sectional survey design, and
collected data through the use of a standardised ques-
tionnaire, which enabled us to draw inferences through
the measurement of casual relations between the varia-
bles at a particular point in time.49 Upon establishing the
research variables, a research questionnaire was
designed to test the hypotheses of the study. The
research tool was based on the five-point Likert scale;
the scale was created such that “5” elicits an outstanding
variable, while “1” elicits an insignificant variable.
Before rolling out the research tool, a preliminary
study was conducted with five market experts and
three medical practitioners. After piloting, the research
tool was corrected for mistakes, clarity, language, and
the proposed model’s coherent flow. Data related to the
constructs were collected via a web-based and in-person
questionnaire.
Survey Population, Sample Size, and Technique
The unit of analysis was hospitals and Drug Therapeutic
Management Committee (DTMC) members in each hos-
pital who handle the medicine supply chain. Out of the
45 general hospitals (GHS), 40 were selected based on
Krejcie and Morgan.50 This assumed 95% statistical sig-
nificance testing level (confidence level). The population
proportion of 0.5% or margin of error/degree of accu-
racy (5%) was expressed as a proportion (.05). From the
40 GHS, a population of 440 DTMC members were
identified, out of which, 320 were selected using simple
random technique (eight from each hospital). The mem-
bers were able to offer insights from which we built
supply chain coordination understanding from a public
hospital perspective. Hence giving equal chance to esti-
mate statistically the characteristics of the population
from the sample. In addition, the respondents are
responsible for planning and forecasting quantifying,
procuring, storing and dispensing medicines. In total,
283 questionnaires were returned, giving a response
rate of 88.4%. The sample was considered adequate
because for factor analysis to be run, a sample size of
at least 100 respondents is recommended,51 even though
the number of variables is less than 20,52 or at least 10
cases for each item in the instrument.53
Operationalization of Variables
Availability refers to the physical presence of the medi-
cine at the service delivery point, in good quality and in
the right quantities, to treat ailments and diseases; timely
delivery of drugs, stock-out frequency and improved
stock levels.54
Collaborative partnerships. This variable entails hospitals
working together in aspects of joint training with
either the supplier, donors or Ministry of Health.27
Information sharing. This refers to the extent to which crit-
ical and proprietary information is communicated to a
supply chain partner. It involves the aspects of accuracy,
timeliness, adequacy and credibility of exchanged infor-
mation. The information shared could be inventory and
order levels, delivery schedules, customer demand and
sales trends.55
Supply-chain interdependence. Interdependency relates to
how the different functions or units within an organiza-
tion connect with each other, given the interdependence
among their internal and external operations through
mutual adjustment, standardization of processes and
joint planning.56 The rest of the variables, as used in
the study, are listed in Table 1.
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Data Evaluation and Reliability Analysis
Structural Equation Modelling (SEM) was used to test
the model. SEM is a multivariate statistical analysis
technique that is used to analyze structural relationships.
This technique is the combination of factor analysis and
multiple regression analysis, and it can be used to ana-
lyze the fundamental relationship between measured
variables and latent constructs. Missing and outliers
were tested before subjecting the data to SEM.57
Overall, 304 questionnaires were completed and
returned. A total of 11 out of 304 were rejected on the
grounds of being incomplete (more than 10% missing
data). In questionnaires with less than 10% missing
data, the median of the nearby point was used to replace
missing data. Ten (10) responses were eliminated due to
disengaged responses, as each variable registered the
same response.
Outliers can significantly impact the correlation and
regression among variables, based on the Mahalanobis
analysis of outliers, and three research tools were
debarred. The symmetry (skewness, S) and tailing (kur-
tosis, K) of the data were also tested; all variables were
in the allowable range of 2S, Tþ2, which elicits
good normality of the data. Cronbach Alpha (CA) was
employed to estimate the internal consistency (IC), and
to determine how closely the measuring variables were
contributing to their respective latent variables. CA
values range from 0.0 to 1.0; CA< 0.70 elicits unaccept-
able consistency, 0.7CA 0.8 elicits acceptable levels,
while CA> 0.8 shows good IC.58 To improve CA, items
with a CA greater than the overall CA were deleted.
Using this approach, one item under the supply chain
interdependence with suppliers (SCI) category was delet-
ed; and the CA for the group soared from 0.699 to 0.760.
The overall CA for the tested variables in this study was
0.838, with no individual group eliciting CA< 0.700, as
shown in Table 2. Thus, the proposed hypothetical
model elicits a good IC and reliability.
Results and Discussions
Demographics
The respondents comprised of 52.3% females and 47.7%
males. The respondents’ qualifications were as follows:
3.2% held secondary school certificates, 24.0% were
diploma holders, 50.2% had bachelor’s degrees, and
18.4% had master’s degrees, while 4.2% had PhDs as
the highest qualification. A total of 7.1% of the respond-
ents had experience of more than ten years, while only
nine respondents had less than one year of experience in
the medical industry. Overall, the demographics elicited
a diverse dataset.
Table 1. Extracted Dimensions and Their Coded Underpinnings.
Collaborative Training (CP)
Code Item
CP01 Joint training with NMS
CP02 Collaborative training with
Drug Monitoring Unit
CP03 Refresher training with the
Ministry of Health
CP04 Collaborative training with NGOs
Information sharing with suppliers (ISS)
ISS 01 Accuracy of shared information.
ISS 02 Regular exchange of information.
ISS 03 Timeliness of information shared
ISS 04 Adequacy of shared information
ISS 05 Sharing of quarterly information
with external stakeholders
ISS06 Sharing of delivery schedules
Supply chain interdependence
SCI 01 Decision synchronization
SCI 02 Pooled interdependence
SCI 03 Reciprocal interdependence
SCI 04 Pooling of resources
SCI 05 Routine regional monitoring
with stakeholders
SCI 06 Evaluation meeting for the
mutual adjustment of plans
Availability of ACTs
A01 Timely delivery of ACTs to user units
A02 Rate of improved stock levels
A03 Right quantities ordered and
received
A04 Right quality in terms of national
quality standards
A05 Stock-out frequency
A06 The rate at which ACTs run out of stock
A07 Observance of minimum–maximum levels
A08 Amount of ACTs available at
the time of the study
Table 2. Reliability Test Based on 283 Respondents and Listwise
Deletion, Based on All Variables in the Procedure.
Group CAa No. of Items
CP 0.815 4
ISS 0.827 5
SCI b 0.760 7
Availability 0.904 8
aOverall CA¼ 0.838; bSeven items remained after deleting one item; ISS:
Information sharing with suppliers; CP: Collaborative partnerships for
training; SCI: Supply chain interdependence with suppliers.
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Confirmatory Factor Analysis and Validity Analysis
Confirmatory factor analysis (CFA) was used to assess
the convergent validity of the hypothetical model. All
the retained variables after CA were subjected to CFA,
and IBMVR SPSSVR Amos (V.21) graphic software was
applied in this analysis. A proposed model to pass
CFA and validity analysis, the average variance
explained (AVE), and composite reliability (CR)
should be  0.50 and 0.70, respectively. The maximum
shared variance (MSV)< average shared variance
(ASV), and the square root of AVE should be higher
than inter-construct correlations.59
The initial values of the hypothetical model are sum-
marized in Table 3. The results shown in the table elicit
abysmal levels of the initial proposed model. To improve
the model outputs, suggestions based on the AMOS
yield were followed. In addition, items with a residual
covariance> j2.0j were eliminated.60 Based on these rec-
ommendations, items SCI01, SCI02, and ISS03 were
eliminated from the model. Their elimination secured
acceptable levels of reliability and validity for the
model. The removal of such items suggests the heteroge-
neous nature of ACT availability, and plummets mea-
surement error, which revved reliability among the
retained items, thus ameliorating model validity.
Table 3 elicits the validity and factor correlation
matrix before and after modification. Figure 1 shows
the CFA measurement after adjustment.
Structural Equation Model
Structural equation model (SEM) was applied to analyze
the multivariate relationship between the measuring var-
iables. AMOS software was used to study the relation-
ship. Maximum likelihood (ML) was employed in the
model evaluation, since there was no problem with uni-
variate normality and the data was normally distribut-
ed.58,59,61 The goodness of fit indices (GOFIs) was tested
using the different parameters, as outlined in Table 4.62
The majority of the GOFIs failed to pass the minimum
requirement. To improve the model fit, covariances and
causal relationships were established among the model
variables and error terms. AMOS modification indices
were used as a baseline to build the interrelationships
amongst the measured parameters.63 As a way of mod-
ifying the model in this regard, covariance relations were
established, as illustrated in Figure 2. For example, the
relationship in the error parameters of “evaluation meet-
ings (SCI06)” with “routine monitoring (SCI05)” and
Table 3. Validity and Factor Correlation Matrix With the Square Root of AVE on the Diagonal.
Proposed Model CR AVE MSV SCI CP ISS AV
SCI 0.757 0.424 0.360 0.651
CP 0.818 0.531 0.001 0.017 0.729
ISS 0.812 0.538 0.100 0.316 0.006 0.733
AV 0.910 0.562 0.360 0.600 0.027 0.307 0.749
Adjusted model CR AVE MSV SCI CP ISS AV
SCI 0.919 0.740 0.361 0.860
CP 0.818 0.531 0.001 0.015 0.729
ISS 0.889 0.670 0.100 0.317 0.001 0.819
AV 0.910 0.562 0.361 0.601 0.027 0.306 0.749
AVE: average variance explained, CR: composite reliability, MSV: maximum shared variance, ASV: average shared variance, ISS: Information sharing with
suppliers, CP: Collaborative partnerships for training, SCI: Supply chain interdependence with suppliers, AV: Availability.
Figure 1. Hypothetical Model Measurement Using CFA. ISS:
Information sharing with suppliers; CP: Collaborative partnerships
for training; SCI: Supply chain interdependence with suppliers;
AVG: Availability; en: error in n
th univariate variable; other varia-
bles are defined in Table 1.
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“timely delivery (A01)” makes theoretical sense. This
creates conceptual sense, as increased evaluation meet-
ings mean revved routine monitoring, which fosters
timely delivery.
Table 4 summarizes the GOFIs of the final model
after several refinements, and all the minimum require-
ments were satisfied. For instance, GFI¼ 0.926, thus the
model outcomes are well explained by the collected data;
RMSEA¼ 0.042, which elicits high confidence levels
amongst variables.
Table 5 elicits the standard regression coefficient of
each retained item in the model. All the path coefficients
are positive and significant at q< 0.05. The two hypoth-
eses, H2 and H3 are supported, based on the data col-
lected from the survey. However, H1 is not supported by
the data. These results suggest that ACTs’ vital supply
chain coordination determinants can be enthused
through information sharing with suppliers and supply
chain interdependence with suppliers. From the forego-
ing results, collaborative partnerships were surprisingly
not supported. Yet partners need to leverage on each
other’s strength to reduce stock-outs.2 This is because
public hospitals by policy only receive medicine supplies
supplied by National Medical Stores (NMS) or Joint
Medical Stores. Enhancing collaborative partnerships
may require a fundamental shift in policy, which will
necessitate ethical considerations to deter partners
from opportunistically misusing their powers.29 These
findings contradict the findings of previous studies30
that revealed that collaborative partnerships were a sig-
nificant predictor of medicine availability. Nonetheless,
without close working relationships with committed sup-
pliers (donors, Non-Governmental Organizations, and
other stakeholders), collaborative training and joint
supervision of medicine usage may be difficult.28
Information sharing emerged as a critical theme in
fostering the availability of ACTs to the populace.
The finding is supported by Mbugua and Namada,46
who assert that information sharing is effective through
information technology tools that lessen system-wide









RMSEA <0.08 0.720 0.042
GFI >0.90 0.879 0.926
AGFI >0.90 0.845 0.900
CFI >0.90 0.932 0.978
NFI >0.90 0.891 0.937
TLI >0.90 0.921 0.973
PCFI >0.50 0.804 0.803
PNFI >0.50 0.681 0.768
RMSEA: Root Mean Square Error of Approximation, GFI: Goodness of Fit
Index, AGFI: Adjusted Goodness of Fit Index, CFI: Comparative Fit Index,
NFI: Normed Fit Index, TLI: Tucker-Lewis Index.
Figure 2. Path Coefficients of the Predictor Model. ISS:
Information sharing with suppliers; CP: Collaborative partnerships
for training; SCI: Supply chain interdependence with suppliers;
AVG: Availability; en: error in n
th univariate variable; other varia-
bles are defined in Table 1.
Table 5. Standardized Regression Weights and Hypothesis Test.
Path Estimate p
AV <- SCI 0.564 ***
AV <- ISS 0.096 0.027
AV <- CP -0.034 0.552
SCI02 <- SCI 0.923 ***
SCI04 <- SCI 0.969 ***
SCI05 <- SCI 0.785 ***
SCI06 <- SCI 0.714 ***
ISS01 <- ISS 0.678 ***
ISS02 <- ISS 0.744 ***
ISS04 <- ISS 0.891 ***
ISS05 <- ISS 0.911 ***
CP01 <- CP 0.621 ***
CP02 <- CP 0.706 ***
CP03 <- CP 0.817 ***
CP04 <- CP 0.756 ***
A01 <- AV 0.662 ***
A02 <- AV 0.770 ***
A03 <- AV 0.850 ***
A04 <- AV 0.789 ***
A05 <- AV 0.843 ***
A06 <- AV 0.559 ***
A07 <- AV 0.731 ***
A08 <- AV 0.500 ***
A06 <- SCI06 0.187 ***
A01 <- ISS05 0.175 ***
A08 <- ISS01 0.175 ***
***Significant at q< 0.001.
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cost implications, while satisfying service requirements.
This then implies that all the stakeholders, particularly
the beneficiaries of malaria drugs, should get the neces-
sary information from government hospitals on where to
obtain the drugs with ease and almost no effort.36,37
Therefore, the hospital must have in place mechanisms
for sharing information in real-time with suppliers and
other external stakeholders.38 The implication is an
investment of resources in procuring appropriate infor-
mation technology that will enable the integration of
functions and systems within the hospitals and with
external partners.40
Supply chain interdependency is the most significant
predictor of medicine availability. The result denotes
that decisions between the general hospitals and NMS
should be synchronized to boost the availability of
ACTs. With integrated systems, decision synchroniza-
tion involving joint decisions in planning could be pos-
sible (SCI02¼ 0.92 and SCI06¼ 0.71). Pooled and
reciprocal interdependence were among the univariate
variables that were retained under supply chain
(SCI04¼ 0.97, and SCI05¼ 0.78). Pooled interdepend-
ence is vital to the efficiency of any kind of operation,
since this form of interdependence has to do with the
joint utilization of resources. By utilizing common
resources, economies of scale can be achieved in the per-
formance of individual activities that belong to different
supply chains.
Where activities are subject to counterpart-specific
interdependence, and hence, are closely complementary,
it is necessary to include reciprocal interdependence in
the supply chains. This interaction may include adjust-
ments of resources used in, or refined by, the activities
subject to coordination to improve resource utilization
or the means by which the activities are coordinated.64
National Medical stores could work closely with the gen-
eral hospitals when deciding to decouple or coordinate
the inbound and outbound flows of inventories to reduce
the ordering and channel inventory costs. The local gov-
ernment or Ministry of Health may have to invest in
developing logistic infrastructure to significantly reduce
the supply chain hurdles.
Conclusions and Implications
Based on the modified SEM model, the findings gener-
ally stick to the assertion that information sharing and
interdependency improvements are significant predictors
of the availability of ACTs. Therefore, it is essential for
DTMC members in hospitals to enhance affordable
information sharing, and manage the interdependency
so as to make medicine available to the end-user. The
implication for hospital management is to develop
affordable information technologies which will be able
to facilitate the information flow between different
stakeholders. By so doing, the hospitals may minimize
manual processes that sometimes are inaccurate and do
not provide the much needed visibility. Taking note of
the interdependence among supply chains partners
implies that that hospitals need to share resources to
the extent that is possible. This may require hospitals
to rethink how to mutually adjust work plans the pool-
ing of resources, and standardization of processes. This
may in turn lead to the improved availability of medi-
cines, to the neediest population, quality of service deliv-
ery, timeliness and reduced costs, which are key facets of
good supply chain performance.
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